Clinical Trial Update: VEGF Trap in Treating Patients With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating aflibercept (VEGF trap) in patients with metastatic breast cancer has completed and posted results in May 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Aflibercept (Aflibercept)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Metastatic Breast Cancer, Recurrent Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-05-05